Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Mohammad Hassan Hodroj
Adjuvant Epigenetic Therapy of Decitabine and Suberoylanilide Hydroxamic Acid Exerts Anti-Neoplastic Effects in Acute Myeloid Leukemia Cells
Cells
Related publications
“Epigenetic” Modification as Therapy for Acute Myeloid Leukemia
Cancer
Cancer Research
Oncology
Awareness of Emerging Novel Epigenetic Targeting Therapy in Acute Myeloid Leukemia
Cancer therapy & Oncology International Journal
Epigenetic Therapy Combinations in Acute Myeloid Leukemia: What Are the Options?
Therapeutic Advances in Hematology
Hematology
Increased Anti-Leukemic Activity of Decitabine via AR-42-induced Upregulation of miR-29b: A Novel Epigenetic-Targeting Approach in Acute Myeloid Leukemia
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
The Epigenetic Landscape of Acute Myeloid Leukemia
Advances in Hematology
Hematology
Pharmacokinetics and Pharmacodynamics of Suberoylanilide Hydroxamic Acid in Cats
Journal of Veterinary Pharmacology and Therapeutics
Veterinary
Pharmacology
A Comparison of Azacitidine and Decitabine Activities in Acute Myeloid Leukemia Cell Lines
PLoS ONE
Multidisciplinary
Therapy of Acute Myeloid Leukemia
Suberoylanilide Hydroxamic Acid Induces Limited Changes in the Transcriptome of Primary CD4+ T Cells
AIDS
Infectious Diseases
Allergy
Immunology
